Becton, Dickinson And Co. Agrees To Pay $175 Million Civil Penalty
The Securities and Exchange Commission on Monday announced it had settled charges against Becton, Dickinson and Company (NYSE:BDX), known as BD, for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its income by failing to record the costs of fixing multiple software flaws with the pump. BD agreed to pay a $175 million civil penalty.
Read More: ‘Mystery Drone’ Sightings Spark Investigations, Politicians Respond: ‘Shoot Them Down,’ Trump Says
“BD repeatedly painted a misleading picture of its Alaris infusion pump for investors and then doubled down by keeping them in the dark when the device’s issues came to a head with the FDA in late 2019,” said Sanjay Wadhwa, Acting Director of …
Full story available on Benzinga.com